Japanese drug maker Otsuka Pharmaceutical Co. is buying U.S.-based Astex Pharmaceuticals for $886 million, Otsuka said Thursday.
Pharmavite, a U.S. manufacturer of vitamins, minerals and other dietary supplements, announced Timothy Toll as its new EVP sales.
The Food and Drug Administration has approved a once-monthly treatment for schizophrenia.
Drug maker Otsuka Pharmaceuticals can keep generic versions of its schizophrenia drug off the market, according to published reports.
The Food and Drug Administration has approved a psychiatric drug for treating bipolar disorder when used in combination with one of two other drugs.
A new women's health, whole soy germ-based nutritional supplement containing natural S-equol reduced the frequency...